PSEN2 and Alzheimer disease: Crenezumab was also used to immunoprecipitate endogenous Aβ from TBS-soluble PS2APP brain homogenates, an amyloidosis mouse model of AD that expresses mutant forms of hAPP (K670N/M671L) and presenilin-2 (PS2N141I).